Ginkgo Bioworks Holdings Inc
NYSE:DNA

  • LAST PRICE
    2.7000
  • TODAY'S CHANGE (%)
    0.3200 (13.4454%)
  • Bid / Lots
    2.6700/ 100
  • Ask / Lots
    2.7000/ 151
  • Open / Previous Close
    2.4000 / 2.3800
  • Day Range
    2.2354
    2.7000
  • 52 Week Range
    2.0900
    15.8640
  • Volume
    26,100,630

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
DNA
Ginkgo Bioworks Holdings Inc
3.5B
-1.7x
---
FOLD
Amicus Therapeutics Inc
3.0B
-11.4x
---
ABCL
Abcellera Biologics Inc
3.0B
15.9x
---
ZLAB
Zai Lab Ltd
3.8B
-1.3x
---
CYTK
Cytokinetics Inc
3.5B
-13.6x
---
ARWR
Arrowhead Pharmaceuticals Inc
3.8B
-36.1x
---
As of 2022-07-05

Company Information

Ginkgo Bioworks Holdings, Inc., formerly Spinning Eagle Acquisition Corp, is engaged in building a platform to program cells. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company's platform is used to design, write, and debug deoxyribonucleic acid (DNA) code in engineered organisms to execute programs for its customers. The Company’s platform comprises of equipment, robotic automation, software, data pipelines and tools, and standard operating procedures for genetic engineering, fermentation, and analytics, a library of proprietary genetic assets and associated performance data; and developers and operators of the foundry and codebase. It serves industries, including chemicals, agriculture, food, consumer products, and pharmaceuticals.

Contact Information

Headquarters
27 Drydock Avenue, 8Th FloorBOSTON, MA, United States 02210
Phone
310-209-7280
Fax
302-655-5049

Executives

President, Founder, Chief Operating Officer, Director
Reshma Shetty
Chief Executive Officer, Founder, Director
Jason Kelly
Chief Financial Officer
Mark Dmytruk
Director
Marijn Dekkers
Independent Director
Arie Belldegrun

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$3.5B
Revenue (TTM)
$482.2M
Shares Outstanding
1.5B
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.61
Book Value
$0.93
P/E Ratio
-1.7x
Price/Sales (TTM)
7.3
Price/Cash Flow (TTM)
---
Operating Margin
-514.94%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.